Episode 14 – Complex assays with Ian Shoemaker, Beckman Coulter Life Sciences & Dr Oksana Sirenko, Molecular Devices
Posted: 1 November 2022 | Drug Target Review | No comments yet
Tune in to this podcast to hear experts discuss 3D cell models, organoids and the automation of complex cell assays.
In this episode, brought to you by Molecular Devices, we cover three-dimensional (3D) organoids and the automation of complex cell assays. We speak with Ian Shoemaker, Senior Application Scientist at Beckman Coulter Life Sciences and Dr Oksana Sirenko, Senior Manager of Assay Development at Molecular Devices.
Listen now to discover how organoid models are developed, used within our experts’ research and how the automation of 3D organoid analysis will evolve in the future, plus much more!
Key learning points:
- Why 3D cell models and 3D organoids are useful in disease research and drug screening
- What a typical workflow for 3D organoid development and analysis looks like
- How to automate organoid development and analysis workflows
- What the automation of 3D organoid analysis will aid in the research of complex systems.
Make sure you don’t miss any new podcasts from Drug Target Review – sign up here to be notified of releases!
Biomarkers aren’t just supporting drug discovery – they’re driving it
FREE market report
From smarter trials to faster insights, this report unpacks the science, strategy and real-world impact behind the next generation of precision therapies.
What you’ll unlock:
- How biomarkers are guiding dose selection and early efficacy decisions in complex trials
- Why multi-omics, liquid biopsy and digital tools are redefining the discovery process
- What makes lab data regulatory-ready and why alignment matters from day one
Explore how biomarkers are shaping early drug development
Access the full report – it’s free!
Ian Shoemaker is Senior Application Scientist at Beckman Coulter Life Sciences and is an expert at translating and scaling novel molecular diagnostic assays from the R&D bench to the robotic deck. He previously managed a cross-functional analytical instrumentation core and has over 10 years of laboratory automation experience including CAP/CLIA accredited clinical laboratory automation and assay development. He holds a BsE in Biological Systems Engineering.
Dr Oksana Sirenko is a Senior Scientist at Molecular Devices and is an expert in developing assays with complex cell-based models. She has previous experience in drug development (Bayer, Novartis) and drug discovery (Fibrogen). Oksana holds a PhD in Biochemistry/Biophysics, has over 15 years of industry experience and has authored over 35 scientific papers.
Related topics
Assays, Cell Cultures, Drug Development, Lab Automation, Organoids, Screening, Targets
Related organisations
Beckman Coulter Life Sciences, Molecular Devices
